Inclusion criteria:
Men and Non-monopausal Women
Hyperlipidemia : TG>200mg/dl , TC>200 mg/dl
Age range 20-55 years
BMI=25 -39.9Kg/m2
Willingness to participate in the study
Exclusion criteria:
Pregnancy, breastfeeding, menopause, oophorectomy, PCOS
Bone, rheumatoid, thyroid, parathyroid, cardiac, hepatic, pulmonary, renal, intestinal diseases, malignancies, and fever
Familial hyperlipidemia
High blood pressure
Family history of premature cardiovascular disease
Diabetes and Prediabetes
LDL>190mg/dl, TG>400mg/d
The need to initiate lipid-lowering therapy based on lipid levels and ASCVD criteria (10-year cardiovascular disease risk).
Obtaining hyperlipidemia medications
Presence of symptoms of an infectious, inflammatory, or surgical condition within the last three months.
Use of insulin, glibenclamide, corticosteroids, or estrogen.
vitamin/mineral supplementation, weight‑loss drugs, or diet/exercise program within 3 months prior to or during the study.
Tobacco, cigarettes, alcohol, or drugs
allergy to quince or its products (e.g., sauce, jam), or quince consumption within the past 3 months."